Screener
Ginkgo Bioworks DNA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Ginkgo Bioworks’s reported figures.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
FAQ
- What is Ginkgo Bioworks's free cash flow?
- Ginkgo Bioworks (DNA) reported free cash flow of -$46.89M in Q2 2026.
- How has Ginkgo Bioworks's free cash flow changed year-over-year?
- Ginkgo Bioworks's free cash flow decreased by 16.4% year-over-year, from -$40.29M to -$46.89M.
- What is the long-term trend for Ginkgo Bioworks's free cash flow?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's free cash flow has grown at a -12.9% compound annual growth rate (CAGR), from -$310.34M to -$178.72M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Ginkgo Bioworks's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude